CSS
RUBY

Cubist Systematic Strategies’s Rubius Therapeutics, Inc RUBY Stock Holding History

Cubist Systematic Strategies’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,270
Closed -$8K – 4808
2022
Q3 		$8K Sell
18,270
-62,785
-77% -$47.1K ﹤0.01% 4302
2022
Q2 		$69K Sell
81,055
-76,731
-49% -$129K ﹤0.01% 4044
2022
Q1 		$869K Buy
157,786
+126,471
+404% +$803K 0.01% 2144
2021
Q4 		$303K Buy
31,315
+22,730
+265% +$315K ﹤0.01% 2792
2021
Q3 		$153K Sell
8,585
-5,257
-38% -$114K ﹤0.01% 2652
2021
Q2 		$338K Buy
13,842
+6,094
+79% +$152K ﹤0.01% 2258
2021
Q1 		$205K Buy
+7,748
New +$113K ﹤0.01% 2462
2020
Q1 		– Sell
-17,789
Closed -$169K – 2561
2019
Q4 		$169K Buy
17,789
+4,031
+29% +$39K ﹤0.01% 2077
2019
Q3 		$108K Buy
+13,758
New +$160K ﹤0.01% 1927

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's RUBY Position: Q4 2022 in Review

Cubist Systematic Strategies sold out of Rubius Therapeutics, Inc (RUBY) in Q4 2022, closing a stake of 18,270 shares — an estimated $8K sold.

Cubist Systematic Strategies first reported a position in RUBY in Q3 2019 and held it in 9 quarters. The position peaked at $869K in Q1 2022. 42 funds tracked by Wall St. Rank hold RUBY as of Q4 2022.

  • Cubist Systematic Strategies reported no remaining Rubius Therapeutics, Inc position as of Q4 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 18,270 Rubius Therapeutics, Inc shares in Q4 2022, an estimated $8K.
  • Cubist Systematic Strategies first reported a position in Rubius Therapeutics, Inc in Q3 2019 and held it in 9 quarters.
  • Cubist Systematic Strategies's Rubius Therapeutics, Inc position peaked at $869K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q4 2022.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.